Authors
Felipe Barros de Andrade Silva, Bruno Bortoluzzi Bellini, Eduardo de Angelis Szikszay, Giulia Santana de Mello, Larrisa Ribeiro Lourenço, Ligia Passos Maia Obi, Juliana Marchi, Maira Smaniotto Cucielo, Roger Borges
Published in
In vitro models. Volume 5. Issue 4. Pages 821-837. Epub Aug 13, 2026.
Abstract
Bone tumor resection often results in critical-sized defects that standard treatments, such as PMMA cement, fail to regenerate effectively due to their bioinert nature. Furthermore, systemic chemotherapy, used to treat remaining cancer cells after tumor resection, lacks specificity and induces severe systemic toxicities. This study aimed to develop and characterize a personalized, 3D-printed composite scaffold made of gelatin methacryloyl (GelMA) and hydroxyapatite (HAp) as a potential dual-action platform for bone tissue engineering and localized carboplatin delivery.
Scaffolds were fabricated using extrusion-based 3D printing. Comprehensive rheological assessments were performed to evaluate printability. The carboplatin release profile was analyzed using different kinetic models, and in vitro bioactivity was assessed in Simulated Body Fluid (SBF). All experiments were performed in triplicate (n = 3).
Rheological characterization showed that HAp incorporation improved shape recovery (from 49 to 90%) despite reduced gel stability and a lower complex elastic modulus. Carboplatin release from GelMA scaffolds follows a mixed Fickian and Case II transport release mechanism described by the Kosmeyer-Peppas model. In contrast, GelMA-HAp scaffolds follow zero-order kinetics, represented by the Hixson-Crowell model, indicating a release mechanism governed by matrix erosion. Bioactivity tests confirmed apatite nucleation on both GelMA and GelMA-HAp surfaces after 1 day in SBF, with HAp-containing scaffolds showing a denser apatite layer.
The 3D-printed GelMA-HAp scaffold serves as a promising bifunctional model, providing a bioactive environment for bone regeneration while ensuring sustained, localized chemotherapeutic release. This personalized approach potentially offers a strategy to bridge the gap between cancer eradication and skeletal restoration.
The online version contains supplementary material available at https://doi.org/10.1007/s44164-026-00150-w.
PMID:
43034339
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0